Skip to main content
. 2019 May 29;4(5):9367–9375. doi: 10.1021/acsomega.9b00535

Figure 3.

Figure 3

(A) Schematic representation of the whole-cell biotransformation of monoterpenes into glucosides using recombinant E. coli cells. (B) In vivo conversion percentage of monoterpenes into respective glucosides using whole cells of E. coli BL21 (DE3) harboring pET28-YjiC at different time intervals. The conversion of all monoterpenes was checked at a 0.5 mM final concentration. A 5% final concentration of sterile glucose was also supplemented at 0, 12, and 24 h.